Raley’s Family of Fine Stores:企業の戦略的SWOT分析

◆英語タイトル:Raley's Family of Fine Stores - Strategic SWOT Analysis Review
◆商品コード:DATA8013743
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月21日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:小売
◆販売価格オプション(消費税別)
Single UserUSD125 ⇒換算¥18,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥36,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥54,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Raley’s Family of Fine Stores – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Raley’s Family of Fine Stores (Raley’s) is a family operated supermarket chain, which provides a wide range of fresh food and non-food products. Its stores offer diverse products including bakery food items; natural foods; gourmet cheeses; wines, beer and spirits; general grocery items; seafood; fruits and vegetables; party trays; generic pharmaceuticals and gluten free products. The company also administers travel immunizations and general immunizations at its selected stores. Raley’s commercializes its merchandise through company owned supermarket stores and ecommerce platform. The company operates an extensive network of stores in Northern California and Nevada under four banners namely, Raley’s Supermarkets, Nob Hill Foods, Bel Air Markets, and Food Source. Raley’s is headquartered in West Sacramento, California, the US.

Raley’s Family of Fine Stores Key Recent Developments

Sep 13,2017: Julie Teel appointed to Raley’s board of directors
Oct 20,2016: Raley’s awarded “National Retailer of the Year” honor by Wine Enthusiast Magazine
Jan 08,2016: Raley’s announces new Senior Vice President of Marketing

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
Section 1 – About the Company 5
Raley’s Family of Fine Stores – Key Facts 5
Raley’s Family of Fine Stores – Key Employees 6
Raley’s Family of Fine Stores – Key Employee Biographies 7
Raley’s Family of Fine Stores – Major Products and Services 8
Raley’s Family of Fine Stores – History 10
Raley’s Family of Fine Stores – Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 – Company Analysis 13
Raley’s Family of Fine Stores – Business Description 13
Raley’s Family of Fine Stores – Corporate Strategy 14
Raley’s Family of Fine Stores – SWOT Analysis 15
SWOT Analysis – Overview 15
Raley’s Family of Fine Stores – Strengths 15
Raley’s Family of Fine Stores – Weaknesses 16
Raley’s Family of Fine Stores – Opportunities 17
Raley’s Family of Fine Stores – Threats 18
Raley’s Family of Fine Stores – Key Competitors 19
Section 3 – Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Raley's Family of Fine Stores, Key Facts 5
Raley's Family of Fine Stores, Key Employees 6
Raley's Family of Fine Stores, Key Employee Biographies 7
Raley's Family of Fine Stores, Major Products and Services 8
Raley's Family of Fine Stores, History 10
Raley's Family of Fine Stores, Subsidiaries 12
Raley's Family of Fine Stores, Key Competitors 19

★海外企業調査レポート[Raley’s Family of Fine Stores:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Chiesi Farmaceutici SpA:製薬・医療:M&Aディール及び事業提携情報
    Summary Chiesi Farmaceutici SpA (Chiesi) researches, develops, produces and commercializes novel medicines with focus on respiratory, neonatology, rare disease and special care therapeutic areas. The company provides products for the treatment of chronic obstructive pulmonary disease (COPD), asthma, …
  • Debiopharm Group:製薬・医療:M&Aディール及び事業提携情報
    Summary Debiopharm Group (Debiopharm) is a biopharmaceutical company that develops biologics and small molecule drug candidates. The company’s product portfolio includes eloxatin, elplat, dacotin, dacplat, decapeptyl, neo decapeptyl, trelstar, pamorelin, salvacyl and moapar, among others. It also of …
  • Allinky Biopharma SL:医療機器:M&Aディール及び事業提携情報
    Summary Allinky Biopharma SL (Allinky) is a developer of small molecules for the treatment of cancer and inflammatory diseases. The company offers research and development of basic and clinical sciences and discovery of novel therapies. Its therapeutic agents comprise active site drugs, target prote …
  • BankAxept AS:企業の戦略・SWOT・財務情報
    BankAxept AS - Strategy, SWOT and Corporate Finance Report Summary BankAxept AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • 3i Infotech Ltd (3IINFOTECH):企業の財務・戦略的SWOT分析
    3i Infotech Ltd (3IINFOTECH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • W&T Offshore, Inc. (WTI)-石油・ガス分野:企業M&A・提携分析
    Summary W&T Offshore, Inc. (W&T Offshore) is an independent oil and natural gas company. It carries out acquisition, exploitation, development and exploration of oil and natural gas assets both onshore and offshore in the Gulf of Mexico. The company acquires rights to explore and develop new prospec …
  • IMAX Corporation:企業のM&A・事業提携・投資動向
    IMAX Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's IMAX Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Statkraft AS:企業のM&A・事業提携・投資動向
    Statkraft AS - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Statkraft AS Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Religare Enterprises Limited:企業のM&A・事業提携・投資動向
    Religare Enterprises Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Religare Enterprises Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Xenon Pharmaceuticals Inc (XENE):企業の財務・戦略的SWOT分析
    Summary Xenon Pharmaceuticals Inc (Xenon), formerly Xenon Genetics Inc, is a biopharmaceutical company that develops medicines to treat neurological disorders. The company is investigating XEN1101, a Kv7 potassium channel modulator against epilepsy; XEN496 for the treatment of seizures associated wi …
  • Bradken Pty Ltd:企業の戦略・SWOT・財務分析
    Bradken Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Bradken Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Environmental Tectonics Corporation:企業の戦略・SWOT・財務情報
    Environmental Tectonics Corporation - Strategy, SWOT and Corporate Finance Report Summary Environmental Tectonics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Gemini Corp (GKX)-石油・ガス分野:企業M&A・提携分析
    Summary Gemini Corporation (Gemini) is an oil and gas engineering company that provides engineering, field and environmental solutions. The company offers services including project management systems, fabrication, maintenance, procurement, construction, land, environmental, regulatory, and reclamat …
  • Columbia Sportswear Co (COLM):企業の財務・戦略的SWOT分析
    Columbia Sportswear Co (COLM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Heineken NV:企業のM&A・事業提携・投資動向
    Heineken NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Heineken NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • PostNL N.V.:企業の戦略・SWOT・財務情報
    PostNL N.V. - Strategy, SWOT and Corporate Finance Report Summary PostNL N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • NGEx Resources Inc:企業のM&A・事業提携・投資動向
    NGEx Resources Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's NGEx Resources Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • WPP Plc (WPP):企業の財務・戦略的SWOT分析
    WPP Plc (WPP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Emcure Pharmaceuticals Ltd:企業の戦略的SWOT分析
    Emcure Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Regenera Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Regenera Pharma Ltd (Regenera Pharma) is a pharmaceutical company that develops a novel drug for neurological indications. The company provides product RPh201, which is a botanical drug developed to repair permanent damages caused by neurological diseases that afflict the central nervous sys …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆